Breaking News, Promotions & Moves

IO Biotech Appoints Faiçal Miyara Chief Business Officer

Miyara will be responsible for global business development activities including strategic partnerships.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

IO Biotech, a clinical-stage biopharmaceutical company developing immune-modulating therapeutic cancer vaccines based on its T-win platform, has appointed Faiçal Miyara, Ph.D., as the company’s chief business officer. Dr. Miyara, who has more than 17 years of experience in the pharmaceutical industry, will be responsible for global business development activities including strategic partnerships. Dr. Miyara will be based in the U.S., report to IO Biotech’s CEO, Mai-Britt Zocca, Ph.D., and be a m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters